214 related articles for article (PubMed ID: 22203032)
1. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
2. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
[TBL] [Abstract][Full Text] [Related]
3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
[TBL] [Abstract][Full Text] [Related]
5. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
7. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
8. Frequency and hemostatic abnormalities in pre-DIC patients.
Okamoto K; Wada H; Hatada T; Uchiyama T; Kawasugi K; Mayumi T; Gando S; Kushimoto S; Seki Y; Madoiwa S; Asakura H; Koga S; Iba T; Maruyama I;
Thromb Res; 2010 Jul; 126(1):74-8. PubMed ID: 20452653
[TBL] [Abstract][Full Text] [Related]
9. Efficacy evaluation of D-dimer and modified criteria in overt and nonovert disseminated intravascular coagulation diagnosis.
Li WJ; Sha M; Ma W; Zhang ZP; Wu YJ; Shi DM
Int J Lab Hematol; 2016 Apr; 38(2):151-9. PubMed ID: 26833979
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Diagnostic Performance of Fibrin Monomer in Comparison to d-Dimer in Patients With Overt and Nonovert Disseminated Intravascular Coagulation.
Singh N; Pati HP; Tyagi S; Upadhyay AD; Saxena R
Clin Appl Thromb Hemost; 2017 Jul; 23(5):460-465. PubMed ID: 26574574
[TBL] [Abstract][Full Text] [Related]
11. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score.
Dempfle CE; Wurst M; Smolinski M; Lorenz S; Osika A; Olenik D; Fiedler F; Borggrefe M
Thromb Haemost; 2004 Apr; 91(4):812-8. PubMed ID: 15045145
[TBL] [Abstract][Full Text] [Related]
12. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
13. [Fibrin monomer assay].
Kobayashi H; Matsuo M; Ikeguchi K; Yamamoto K; Kario K; Matsuo T
Rinsho Byori; 1991 Jul; 39(7):689-93. PubMed ID: 1920860
[TBL] [Abstract][Full Text] [Related]
14. Use of fibrin monomer and D-Dimer in assessing overt and nonovert disseminated intravascular coagulation.
Zheng X; Chen S; Zhang F; Ye M; Chen J; Zhang S
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):248-252. PubMed ID: 33955858
[TBL] [Abstract][Full Text] [Related]
15. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.
Oh D; Jang MJ; Lee SJ; Chong SY; Kang MS; Wada H
Thromb Res; 2010 Jul; 126(1):18-23. PubMed ID: 20079919
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
19. Limited utility of a rapid quantitative enzyme-linked fluorescent assay for the D-dimer in the diagnosis of overt disseminated intravascular coagulation.
Sharma P; Saxena R
Clin Appl Thromb Hemost; 2010 Dec; 16(6):609-13. PubMed ID: 20211928
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
